| Name | Title | Contact Details |
|---|
At Mako Fire Group our main goal is helping you protect what matters most, and we take great pride in that. Our companies highly qualified technicians undergo a rigorous training surpassing what is required of them from local and state governments to ensure the highest level of satisfaction for our customers. Offering a wide array of cutting edge products including fire extinguishers, exit and emergency lights, smoke detection/alarms, etc. we are your one stop shop for fire prevention and protection. Annual services for commercial properties include Fire extinguisher maintenance, smoke alarm maintenance, emergency lighting maintenance, fire alarm maintenance, sprinkler maintenance, etc. With a corporate sized workforce and mom-and-pop style customer service, we at Mako Fire Group guarantee we will meet and exceed all your expectations.
At Prosperity Bank, we believe in a community banking philosophy where personal relationships and great experiences go hand-in-hand. We provide convenient technology options that our customers expect – all backed by the highest level of security. At every touch point, youll find knowledgeable associates ready to serve our customers with accuracy and a smile time and time again. Prosperity provides personal banking services and investments to consumers and small to medium sized businesses throughout Texas and Oklahoma. Founded in 1983, Prosperity ranks among the top 100 U.S. banks in assets. Member FDIC. Equal Housing Lender.
AESSEAL designs and manufactures sealing solutions for a sustainable future. We work with global customers in every major industrial sector to improve the reliability, safety and environmental performance of industrial equipment. An industry pioneer, we were founded in 1979 and operate from 231 locations in 104 countries, with a total focus on achieving exceptional quality: in terms of products, technical innovation, customer service, after sales support and care for the environment.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.